WHO IS A GOOD CANDIDATE FOR VIVEVE?
POST-CHILDBIRTH VAGINAL LAXITY
Difficulties with vaginal looseness and overstretched tissue following childbirth often cause reduced sexual sensitivity and urinary incontinence. This relaxed tissue is known as vaginal laxity, which is often found in new mothers and results from the expansion of the vagina to accommodate a baby while it makes its way through the birth canal. This condition can lead to a decline in female sexual function, poor body image and overall reduced quality of life. Thankfully, the new VIVEVE treatment can aid those suffering, regardless of if it’s after their first baby or their fifth. Mothers can now receive the procedure as soon as 8 to 12 weeks following childbirth and finally see the improvements they have been searching for after just a few weeks.
Women often struggle with a lack of vaginal rigidity and sensitivity, which can cause detriments in sexual stimulation over time. This loose tissue and resulting negative symptoms can often stem from hormone imbalance, childbirth, a medical condition, or age. Women struggling with these issues now have the option of the advanced VIVEVE treatment to generate a natural rejuvenation of your tissue, encouraging the vaginal wall to provide more lubrication and sensitivity during sex. The innovative technology can gently use radio frequencies to repair existing tissue to help restore the elastin and collagen that make for a healthy, tight and sensitive vagina. Now women who sometimes experience a loss of sensitivity or inadequate climax sensations during sex due to vaginal laxity can see long lasting results in the quality and intensity of climaxes with the help of the VIVEVE procedure.
VAGINAL LAXITY AND URINARY INCONTINENCE
Stress incontinence is the inability to prevent leaking urine when coughing, sneezing, laughing, or exercising. Women may also deal with a strong need to urinate, but struggle getting to the toilet in time, this is referred to as urge incontinence. These forms of urinary incontinence are more common among women, especially menopausal, postpartum or postmenopausal women. Most often incontinence in menopausal and postmenopausal women is due to vaginal laxity from a decrease in collagen and the deterioration of estrogen levels, which reduce the vulvo-vaginal mucosa. The VIVEVE treatment stimulates collagen growth to improve vaginal laxity through a non-invasive, low-risk application of heat to the vaginal wall. As the tissue replenishes, the vaginal wall becomes more pliant and supple, and the tightness improves your body’s ability to properly manage urine flow.
Q: Is the treatment painful?
A: During the treatment, most women experience a sensation of heating and cooling, but usually no discomfort or pain.
Q: How long is the VIVEVE treatment?
A: The non-invasive, low-risk procedure takes approximately 30 minutes to complete in our office.
Q: Can I go back to work right after the treatment?
A: Yes. In most cases, you can return to normal activity immediately following your treatment.
Q: Are there any side effects during or after the treatment?
A: Most women don’t experience any side effects during the procedure or afterward.
Q: What is Radio Frequency technology?
A: Radio frequency (RF) technology has been used in medical applications for over 75 years. Systems based on radio frequency have been successfully used for non-ablative skin rejuvenation, treatment of unwanted hair, atrophic scar revision, inflammatory acne and vascular lesions. The radio frequency device produces a heating of the collagen helix in the applied area, causing proteins to reform and rebuild.